Abpro has a highly talented team of immunoassay scientists with extensive assay development experience.  Our team has delivered high quality, functional monoclonal antibodies and corresponding assays to traditionally difficult targets (e.g., GPCRs, high homology proteins, idiotypes).  Our expertise includes, but is not limited to sandwich ELISAs for diagnostic kit development, competition, neutralizing, and blocking assays for drug screening and development.

In addition to assay development, we also have high throughput screening capabilities.  Our platform leverages state-of-the-art automation to process and screen a huge volume of samples accurately and efficiently. Our screening capabilities include:

  • Affinity Ranking (ForteBio Octet™)
  • Western Blots
  • Flow Cytometry
  • Immunoprecipitation
  • Dot Blot

Assay development and high throughput screening can be included as part of a custom antibody development project or offered as an independent service.

About Us
Abpro is a Massachusetts based biotechnology company. We are pioneers of industrial biochemistry and our mission is to bring innovation to the life sciences industry and ultimately improve living health. Through technology and automation, our DiversImmune™ discovery platform has streamlined all aspects of the process to deliver antibodies at industry leading speeds against previously difficult targets. Our products and discovery services are used by leading academic labs and companies around the world for research purposes, such as diagnostics and therapeutics.